Modified release of furosemide from Eudragits® and poly(ethylene oxide)-based matrices and dry-coated tablets
Modified release of furosemide from tablet formulations is preferred by patients, because of physiological problems, acute diuresis being the most serious, compared to the forms designed for immediate release. With this in view, we aimed at achieving furosemide’s longer gastric retention and waste m...
Main Authors: | Vlachou Marilena, Geraniou Efthymia, Siamidi Angeliki |
---|---|
Format: | Article |
Language: | English |
Published: |
Sciendo
2020-03-01
|
Series: | Acta Pharmaceutica |
Subjects: | |
Online Access: | https://doi.org/10.2478/acph-2020-0010 |
Similar Items
-
Development and Characterization of Eudragit<sup>®</sup>-Based Electrospun Nanofibrous Mats and Their Formulation into Nanofiber Tablets for the Modified Release of Furosemide
by: Marilena Vlachou, et al.
Published: (2019-09-01) -
Optimized furosemide taste masked orally disintegrating tablets
by: Mohamed Abbas Ibrahim, et al.
Published: (2017-11-01) -
Eudragit FS 30D as a potential polymer for use in the technology of preparing matrix tablets contain metronidazole – an experimental and mathematical modeling study
by: Letmanski Tomasz, et al.
Published: (2015-06-01) -
Formulation and in vitro evaluation of Eudragit S-100 coated naproxen matrix tablets for colon-targeted drug delivery system
by: Rohit Mehta, et al.
Published: (2013-01-01) -
Probing the Release of Bupropion and Naltrexone Hydrochloride Salts from Biopolymeric Matrices of Diverse Chemical Structures
by: Angeliki Siamidi, et al.
Published: (2021-04-01)